Scientists explore longevity drugs for dogs that could also extend human life'
Briefly

Celine Halioua, founder and CEO of Loyal, emphasizes that understanding how to prevent age-related decline in dogs can provide critical insights into similar processes in humans, as dogs share our environments and health issues.
LOY-002 aims to reduce the metabolic changes linked to aging in dogs, with a focus on decreasing frailty and reversing insulin-related increases as dogs grow older, enhancing their lifespan in a healthy manner.
Read at www.theguardian.com
[
|
]